144 related articles for article (PubMed ID: 8542575)
1. The effect of tobacco on lung cancer risk depends on CYP2D6 activity.
Bouchardy C; Benhamou S; Dayer P
Cancer Res; 1996 Jan; 56(2):251-3. PubMed ID: 8542575
[TBL] [Abstract][Full Text] [Related]
2. Effects of CYP2D6 activity and tobacco on larynx cancer risk.
Benhamou S; Bouchardy C; Paoletti C; Dayer P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):683-6. PubMed ID: 8877058
[TBL] [Abstract][Full Text] [Related]
3. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
4. Association between lung cancer and microsomal epoxide hydrolase genotypes.
Benhamou S; Reinikainen M; Bouchardy C; Dayer P; Hirvonen A
Cancer Res; 1998 Dec; 58(23):5291-3. PubMed ID: 9850050
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer in lifetime nonsmoking men - results of a case-control study in Germany.
Kreuzer M; Gerken M; Kreienbrock L; Wellmann J; Wichmann HE
Br J Cancer; 2001 Jan; 84(1):134-40. PubMed ID: 11139328
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism of CYP2D6 and lung cancer risk.
Shaw GL; Falk RT; Frame JN; Weiffenbach B; Nesbitt JC; Pass HI; Caporaso NE; Moir DT; Tucker MA
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):215-9. PubMed ID: 9521436
[TBL] [Abstract][Full Text] [Related]
7. The effect of alcohol on the risk of lung cancer in Uruguay.
De Stefani E; Correa P; Fierro L; Fontham ET; Chen V; Zavala D
Cancer Epidemiol Biomarkers Prev; 1993; 2(1):21-6. PubMed ID: 8380549
[TBL] [Abstract][Full Text] [Related]
8. Squamous and small cell carcinomas of the lung: similarities and differences concerning the role of tobacco smoking.
De Stefani E; Boffetta P; Ronco AL; Brennan P; Correa P; Deneo-Pellegrini H; Gutiérrez LP; Mendilaharsu M
Lung Cancer; 2005 Jan; 47(1):1-8. PubMed ID: 15603849
[TBL] [Abstract][Full Text] [Related]
9. Lung carcinoma in former smokers.
Tong L; Spitz MR; Fueger JJ; Amos CA
Cancer; 1996 Sep; 78(5):1004-10. PubMed ID: 8780538
[TBL] [Abstract][Full Text] [Related]
10. A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking.
Liang G; Miao X; Zhou Y; Tan W; Lin D
Carcinogenesis; 2004 May; 25(5):773-8. PubMed ID: 14688021
[TBL] [Abstract][Full Text] [Related]
11. [Studies on relationship between passive smoking and lung cancer in non-smoking women].
Zheng S; Fan R; Wu Z
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 May; 31(3):163-5. PubMed ID: 9812596
[TBL] [Abstract][Full Text] [Related]
12. CYP2D6 genotype and the incidence of anal and vulvar cancer.
Chen C; Cook LS; Li XY; Hallagan S; Madeleine MM; Daling JR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):317-21. PubMed ID: 10207635
[TBL] [Abstract][Full Text] [Related]
13. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism.
Malats N; Camus-Radon AM; Nyberg F; Ahrens W; Constantinescu V; Mukeria A; Benhamou S; Batura-Gabryel H; Bruske-Hohlfeld I; Simonato L; Menezes A; Lea S; Lang M; Boffetta P
Cancer Epidemiol Biomarkers Prev; 2000 Aug; 9(8):827-33. PubMed ID: 10952100
[TBL] [Abstract][Full Text] [Related]
16. Smoking and smoking-related lung cancer in female patients.
Satoh H; Yamashita YT; Ishikawa H; Kamma H; Ohtsuka M; Sekizawa K
Anticancer Res; 1999; 19(6C):5627-30. PubMed ID: 10697630
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin intervention on the relationship between GSTM1, smoking, and lung cancer risk among male smokers.
Woodson K; Stewart C; Barrett M; Bhat NK; Virtamo J; Taylor PR; Albanes D
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):965-70. PubMed ID: 10566550
[TBL] [Abstract][Full Text] [Related]
18. [Metabolic polymorphisms and the cancer risk: the evaluation of epidemiological studies].
Vineis P; Landi MT; Caporaso N
Med Lav; 1992; 83(6):557-75. PubMed ID: 1296137
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers.
Harris RE; Beebe-Donk J; Schuller HM
Oncol Rep; 2002; 9(4):693-5. PubMed ID: 12066194
[TBL] [Abstract][Full Text] [Related]
20. Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan.
Chang CH; Hsiao CF; Chang GC; Tsai YH; Chen YM; Huang MS; Su WC; Hsieh WS; Yang PC; Chen CJ; Hsiung CA
Am J Epidemiol; 2009 Sep; 170(6):695-702. PubMed ID: 19671832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]